We are international
Donate
TEXT SIZE   
   back

ASH 2011: Dr. Ludwig - Bortezomib-Bendamustine-Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma (MM) Shows Marked Efficacy and Is Well Tolerated, but Assessment of PNP Symptoms Shows Significant Discrepancies Between Patients and Physicians
Heinz Ludwig, MD
Wilhelminenhospital
Vienna, Austria
12.06.11

Be the first to comment

 related articles